Droxidopa's generic name is droxidopa.
What is Droxidopa used for?
Droxidopa is a medication prescribed to treat neurogenic orthostatic hypotension (NOH) [1]. This condition causes a significant drop in blood pressure when standing up, leading to symptoms like dizziness, lightheadedness, and fainting [1].
How does Droxidopa work?
Droxidopa is a synthetic amino acid that acts as a prodrug, meaning it is converted in the body into norepinephrine [1]. Norepinephrine is a neurotransmitter and hormone that helps to constrict blood vessels, thereby increasing blood pressure and reducing the symptoms of NOH [1].
When does Droxidopa's patent expire?
Information regarding the specific patent expiry dates for droxidopa can be found on DrugPatentWatch.com [2]. Patent protection is crucial for pharmaceutical companies as it grants them exclusive rights to market their drugs for a certain period, allowing them to recoup research and development costs.
Can generic versions of Droxidopa be made?
Once patent protection for a drug expires, other pharmaceutical companies can seek approval to manufacture and market generic versions. These generic versions typically contain the same active ingredient as the brand-name drug and are bioequivalent [3]. The availability of generic alternatives can lead to lower drug prices.
What are the risks or side effects of Droxidopa?
Common side effects of droxidopa include headache, dizziness, nausea, high blood pressure, and stomach pain [1]. Serious side effects are less common but can include supine hypertension (high blood pressure while lying down), urinary tract infection, and constipation [1]. Patients should discuss potential risks with their healthcare provider.